Clinical Trials · NCT05649137
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 512
- Start date
- Jan 2023
- Locations
- 76 sites, 8 countries
- Primary endpoint
- Relative Change in Body Weight